Core Laboratories Inc. (NYSE:CLB) Shares Sold by Fisher Asset Management LLC

Fisher Asset Management LLC reduced its stake in Core Laboratories Inc. (NYSE:CLB) by 4.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 941,269 shares of the oil and gas company’s stock after selling 48,998 shares during the quarter. Fisher Asset Management LLC’s holdings in Core Laboratories were worth $16,293,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. State Street Corp lifted its holdings in shares of Core Laboratories by 2.9% in the 3rd quarter. State Street Corp now owns 1,975,016 shares of the oil and gas company’s stock worth $36,597,000 after acquiring an additional 56,187 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Core Laboratories by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 1,053,204 shares of the oil and gas company’s stock worth $19,521,000 after acquiring an additional 7,721 shares during the last quarter. Boston Trust Walden Corp lifted its holdings in shares of Core Laboratories by 2.7% in the 4th quarter. Boston Trust Walden Corp now owns 617,336 shares of the oil and gas company’s stock worth $10,686,000 after acquiring an additional 16,503 shares during the last quarter. Barclays PLC lifted its holdings in Core Laboratories by 288.2% during the 3rd quarter. Barclays PLC now owns 83,570 shares of the oil and gas company’s stock worth $1,549,000 after buying an additional 62,042 shares in the last quarter. Finally, Van ECK Associates Corp lifted its holdings in Core Laboratories by 6.3% during the 4th quarter. Van ECK Associates Corp now owns 443,621 shares of the oil and gas company’s stock worth $7,679,000 after buying an additional 26,237 shares in the last quarter. 97.81% of the stock is currently owned by institutional investors and hedge funds.

Core Laboratories Trading Down 4.9 %

Shares of NYSE:CLB opened at $13.91 on Tuesday. Core Laboratories Inc. has a 52 week low of $13.70 and a 52 week high of $25.13. The company’s 50 day moving average is $17.60 and its two-hundred day moving average is $18.57. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49. The company has a market cap of $651.27 million, a PE ratio of 21.07, a P/E/G ratio of 0.99 and a beta of 2.38.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings data on Wednesday, January 29th. The oil and gas company reported $0.23 EPS for the quarter, meeting analysts’ consensus estimates of $0.23. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. Equities analysts predict that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.

Core Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Monday, February 10th were given a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.29%. The ex-dividend date of this dividend was Monday, February 10th. Core Laboratories’s dividend payout ratio is presently 6.06%.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on CLB shares. Citigroup increased their target price on shares of Core Laboratories from $14.00 to $15.00 and gave the stock a “sell” rating in a report on Thursday, February 20th. StockNews.com upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $17.25.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.